Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Jun;82(6):470–473. doi: 10.1136/adc.82.6.470

Current approaches to the management of primary hyperoxaluria

P Cochat 1, O Basmaison 1
PMCID: PMC1718347  PMID: 10833178

Full Text

The Full Text of this article is available as a PDF (86.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cochat P., Koch Nogueira P. C., Mahmoud M. A., Jamieson N. V., Scheinman J. I., Rolland M. O. Primary hyperoxaluria in infants: medical, ethical, and economic issues. J Pediatr. 1999 Dec;135(6):746–750. doi: 10.1016/s0022-3476(99)70095-8. [DOI] [PubMed] [Google Scholar]
  2. Cochat P. Primary hyperoxaluria type 1. Kidney Int. 1999 Jun;55(6):2533–2547. doi: 10.1046/j.1523-1755.1999.00477.x. [DOI] [PubMed] [Google Scholar]
  3. Cramer S. D., Ferree P. M., Lin K., Milliner D. S., Holmes R. P. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet. 1999 Oct;8(11):2063–2069. doi: 10.1093/hmg/8.11.2063. [DOI] [PubMed] [Google Scholar]
  4. Giafi C. F., Rumsby G. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem. 1998 Jan;35(Pt 1):104–109. doi: 10.1177/000456329803500114. [DOI] [PubMed] [Google Scholar]
  5. Jamieson N. V. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol. 1998 Mar-Apr;11 (Suppl 1):36–41. [PubMed] [Google Scholar]
  6. Jouvet P., Priqueler L., Gagnadoux M. F., Jan D., Beringer A., Lacaille F., Revillon Y., Broyer M., Daudon M. Crystalluria: a clinically useful investigation in children with primary hyperoxaluria post-transplantation. Kidney Int. 1998 May;53(5):1412–1416. doi: 10.1046/j.1523-1755.1998.00876.x. [DOI] [PubMed] [Google Scholar]
  7. Kamoun A., Daudon M., Zghal A., Lasram L., Ben Maiz H., Belkahia C., Lakhoua R. Hyperoxalurie primitive: l'expérience tunisienne à propos de 24 cas pédiatriques. Nephrologie. 1997;18(2):59–64. [PubMed] [Google Scholar]
  8. Kemper M. J., Conrad S., Müller-Wiefel D. E. Primary hyperoxaluria type 2. Eur J Pediatr. 1997 Jul;156(7):509–512. doi: 10.1007/s004310050649. [DOI] [PubMed] [Google Scholar]
  9. Latta K., Brodehl J. Primary hyperoxaluria type I. Eur J Pediatr. 1990 May;149(8):518–522. doi: 10.1007/BF01957682. [DOI] [PubMed] [Google Scholar]
  10. Leiper J. M., Danpure C. J. A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1. Clin Chim Acta. 1997 Oct 9;266(1):39–50. doi: 10.1016/s0009-8981(97)00165-4. [DOI] [PubMed] [Google Scholar]
  11. Leumann E., Hoppe B., Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol. 1993 Apr;7(2):207–211. doi: 10.1007/BF00864405. [DOI] [PubMed] [Google Scholar]
  12. Leumann E., Hoppe B. What is new in primary hyperoxaluria? Nephrol Dial Transplant. 1999 Nov;14(11):2556–2558. doi: 10.1093/ndt/14.11.2556. [DOI] [PubMed] [Google Scholar]
  13. Marangella M. Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness. Nephrol Dial Transplant. 1999 Feb;14(2):301–303. doi: 10.1093/ndt/14.2.301. [DOI] [PubMed] [Google Scholar]
  14. Milliner D. S., Eickholt J. T., Bergstralh E. J., Wilson D. M., Smith L. H. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med. 1994 Dec 8;331(23):1553–1558. doi: 10.1056/NEJM199412083312304. [DOI] [PubMed] [Google Scholar]
  15. Milliner D. S., Wilson D. M., Smith L. H. Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol. 1998 Mar-Apr;11 (Suppl 1):56–59. [PubMed] [Google Scholar]
  16. Tarn A. C., von Schnakenburg C., Rumsby G. Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT). J Inherit Metab Dis. 1997 Sep;20(5):689–696. doi: 10.1023/a:1005326510239. [DOI] [PubMed] [Google Scholar]
  17. Toussaint C., De Pauw L., Vienne A., Gevenois P. A., Quintin J., Gelin M., Pasteels J. L. Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in primary hyperoxaluria type 1. Am J Kidney Dis. 1993 Jan;21(1):54–63. doi: 10.1016/s0272-6386(12)80722-0. [DOI] [PubMed] [Google Scholar]
  18. Van Acker K. J., Eyskens F. J., Espeel M. F., Wanders R. J., Dekker C., Kerckaert I. O., Roels F. Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria. Kidney Int. 1996 Nov;50(5):1747–1752. doi: 10.1038/ki.1996.494. [DOI] [PubMed] [Google Scholar]
  19. Watts R. W., Calne R. Y., Williams R., Mansell M. A., Veall N., Purkiss P., Rolles K. Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation. Q J Med. 1985 Oct;57(222):697–703. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES